EDA-fibronectin defines an early molecular target for imaging cardiac remodeling
Fibrotic remodeling is a primary driver of heart failure, yet early molecular events remain difficult to detect non-invasively. Cellular fibronectin (cFN), an alternatively spliced fibronectin isoform containing the extra domain A (EDA), is rapidly induced during early tissue repair and precedes collagen deposition. This study identifies the molecular target responsible for myocardial uptake of 18 F-fluoroglucaric acid (FGA) and determines whether this tracer can report early extracellular matrix remodeling associated with cardiac injury. We employed an integrated approach combining quantitative SILAC-based proteomics, microscale thermophoresis (MST), and competitive binding assays. Using a biotinylated surrogate (BGA), tracer kinetics and target specificity were evaluated in human AC16 cardiomyocytes under ischemic and profibrotic stress. In vivo validation was performed using PET/CT imaging and biodistribution studies in murine models of cardiac injury, including isoproterenol-induced cardiomyopathy and autoimmune myocarditis. Proteomic profiling identified fibronectin as the primary interacting partner of surrogate BGA. MST revealed that FGA binds cFN with submicromolar affinity (Kd ≈ 0.42 µM), while showing substantially weaker, micromolar-range binding to plasma fibronectin (Kd ≈ 7.6 µM). In vivo, 18 F-FGA uptake was significantly elevated in damaged myocardium and strongly correlated with EDA-FN expression (r 2 = 0.92; Pearson r = 0.958, 95% CI 0.661–0.996; p = 0.0026, n = 6). Temporal analyses in cellular and tissue models indicated that cFN induction and BGA accumulation occur early in fibrogenesis, preceding significant collagen deposition. 18 F-FGA preferentially and EDA-dependently associates with cFN, a marker of early extracellular matrix activation, supporting its potential as a candidate PET probe for early cardiac remodeling. Direct characterization of the binding interface and longitudinal in vivo studies will be required to confirm detection of a pre-fibrotic state.
Authors
- Vibhudutta Awasthi (ORCID: https://orcid.org/0000-0002-3611-9009)
- Venkateswararao Eeda (ORCID: https://orcid.org/0000-0003-2740-047X)
- Andria Hedrick (ORCID: https://orcid.org/0000-0002-4443-7509)
- Tarun W. Dasari (ORCID: https://orcid.org/0000-0002-4204-1279)
- Hung Anh Nguyen
- Andrea S. Ramirez-Sagredo
- Maitreyee Das
Institutions
- Oklahoma City University (US)
- University of Oklahoma (US)
Publication Details
- Journal
- Journal of Translational Medicine
- Published
- 2026-08-25
- DOI
- https://doi.org/10.1186/s12967-026-08850-3
- Primary Topic
- Cardiac Fibrosis and Remodeling
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Heart, Lung, and Blood Institute